FDA approves nasal spray to reverse fentanyl, other opioid overdoses

United States News News

FDA approves nasal spray to reverse fentanyl, other opioid overdoses
United States Latest News,United States Headlines
  • 📰 FOX26Houston
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 53%

U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl and other opioids driving the nation's drug crisis.

of heroin, fentanyl and prescription painkillers. Both work by blocking the effects of opioids in the brain, which can restore normal breathing and blood pressure in people who have recently overdosed.

A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. Because fentanyl stays in the body longer than heroin and other opioids, some people may require multiple doses of naloxone over several hours to fully reverse an overdose.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

FOX26Houston /  🏆 448. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA Approves Autoinjector Pen for Humira Biosimilar, CyltezoFDA Approves Autoinjector Pen for Humira Biosimilar, CyltezoThe FDA approved a new autoinjection option for adalimumab-adbm, a biosimilar to AbbVie's adalimumab, ahead of Cyltezo's commercial launch on July 1, 2023.
Read more »

FDA Approves First Pill to Treat Moderate-to-Severe Crohn's DiseaseFDA Approves First Pill to Treat Moderate-to-Severe Crohn's DiseaseRinvoq is meant to treat adults with moderately to severely active Crohn's disease who have not had success with TNF (tumor necrosis factor) blockers. The daily pill is the first oral treatment for this group of patients.
Read more »

Veozah, new menopause drug for hot flashes, wins FDA approvalVeozah, new menopause drug for hot flashes, wins FDA approval“It’s going to be completely game changing for a lot of women,” one endocrinologist said.
Read more »

FDA Okays Treatment for Dry Eye DiseaseFDA Okays Treatment for Dry Eye DiseasePatients with evaporative dry eye disease will soon have a new treatment option targeting excessive tear evaporation.
Read more »



Render Time: 2025-02-23 10:54:00